-
More Options for Treating MelanomaWith targeted drugs, immunotherapies and treatment combinations now available, people with advanced melanoma have choices to make.
by Kendall K. Morgan
-
Survivor Profile
A Plan of ActionJamil Rivers supported her husband through two serious illnesses before she was diagnosed with metastatic breast cancer. Her experiences as a Black woman undergoing treatment inspired her to tackle health inequities.
by Queen Muse
-
Forward Look
Putting Data to WorkResearchers create breast cancer prediction models tailored for Asian Americans.
by Bradley Jones
-
Forward Look
New Treatment Approved for Lung CancerKRAS mutations were once thought to be resistant to drug therapy.
by Carisa Brewster
-
Forward Look
Spotlight on Small Cell Lung CancerTreatments for small cell lung cancer have remained virtually the same for decades. Now, experts say that hope is on the horizon.
by Isobel Whitcomb
-
Forward Look
What’s Next? Fall 2021Oncolytic viruses to treat pediatric glioma.
by Natalie Slivinski
-
Facts and Stats
Looking Closely at Lung CancerWhile there are many kinds of lung cancer, screening recommendations are standard across the board.
by Bradley Jones
-
Forward Look
Predicting Colorectal Cancer RecurrenceLiquid biopsy tests can find tiny amounts of disease that remain after surgery and chemotherapy.
by Kris Conner
-
An Emerging Treatment for Metastatic Prostate CancerA drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.
by Pamela Rafalow Grossman
-
Drug Delays Recurrence in People With Early-Stage Breast CancerPeople who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
by Pamela Rafalow Grossman
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
